Previously treated cases tested for RR-/MDR-TB in Central African Republic

Central African Republic: Previously treated cases tested for RR-/MDR-TB was 90.0% in 2024. ◆ Volatile

Latest (2024)
90.0%
Change on year
up 233.3%
World rank
83rd
of 180 countries
All-time high
90.0%
in 2024
All-time low
0.0%
in 2010
Years of data
16
2008–2024

Previously treated cases tested for RR-/MDR-TB in Central African Republic, 2008–2024

0204060801002008201620242008: 5.62009: 3.32010: 02011: 162013: 9.42014: 02015: 142016: 342017: 622018: 552019: 352020: 152021: 212022: 382023: 272024: 90

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for previously treated cases tested for rr-/mdr-tb in Central African Republic is 90.0%, measured in 2024. That is the highest value across all 16 years on record.

Compared with earlier readings it is up 233.3% on the previous year and up 157.1% over five years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Central African Republic peaked at 90.0% in 2024 and was at its lowest, 0.0%, in 2010.

That places Central African Republic 83rd out of 180 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Central African Republic, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Central African Republic, 2008 to 2024.
Year Value Change
2008 5.6%
2009 3.3% -41.1%
2010 0.0% -100.0%
2011 16.0%
2013 9.4% -41.2%
2014 0.0% -100.0%
2015 14.0%
2016 34.0% +142.9%
2017 62.0% +82.4%
2018 55.0% -11.3%
2019 35.0% -36.4%
2020 15.0% -57.1%
2021 21.0% +40.0%
2022 38.0% +81.0%
2023 27.0% -28.9%
2024 90.0% +233.3%

Averages by decade

DecadeAverage LowestHighest Years
2000s 4.4% 3.3% 5.6% 2
2010s 25.0% 0.0% 62.0% 9
2020s 38.2% 15.0% 90.0% 5

Countries ranked near Central African Republic

  1. 82 Tajikistan 91.0% compare
  2. 83 Mongolia 90.0% compare
  3. 83 Bolivia, Plurinational State of 90.0% compare
  4. 83 Malawi 90.0% compare

See the full ranking of 192 places →

More health data for Central African Republic

All data for Central African Republic →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Central African Republic?
Previously treated cases tested for rr-/mdr-tb in Central African Republic was 90.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Central African Republic?
The highest recorded value was 90.0% in 2024.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Central African Republic?
The lowest recorded value was 0.0% in 2010.
How does Central African Republic rank for previously treated cases tested for rr-/mdr-tb?
Central African Republic ranks 83rd out of 180 countries with data for 2024.
Where does this Central African Republic data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Central African Republic. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 30 August 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/central-african-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/central-african-republic/">Previously treated cases tested for RR-/MDR-TB in Central African Republic</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
192 places, 3,071 data points, 2005–2024
Last refreshed